Shanghai Composite Index Rises 1.16% This Week to 3017.78 — Data Talk
The Shanghai Composite Index is up 34.73 points or 1.16% this week to 3017.78
--Largest one-week point and percentage gain since the week ending Sept. 1, 2023
--Snaps a three-week losing streak
--Today it is up 29.49 points or 0.99%
--Largest one-day point and percentage gain since Friday, Sept. 22, 2023
--Up for four consecutive trading days
--Up 78.49 points or 2.67% over the last four trading days
--Largest four-day point and percentage gain since Friday, July 28, 2023
--Longest winning streak since Friday, April 7, 2023 when the market rose for six straight trading days
--Off 50.46% from its record close of 6092.06 hit Tuesday, Oct. 16, 2007
--Today's closing value is the seventh lowest this year
--Highest closing value since Wednesday, Oct. 18, 2023
--Off 11.11% from its 52-week high of 3395.00 hit Monday, May 8, 2023
--Up 4.30% from its 52-week low of 2893.48 hit Monday, Oct. 31, 2022
--Rose 3.49% from 52 weeks ago
--Off 11.11% from its 2023 closing high of 3395.00 hit Monday, May 8, 2023
--Up 2.67% from its 2023 closing low of 2939.29 hit Monday, Oct. 23, 2023
--Month-to-date it is down 2.98%
--Year-to-date it is down 71.47 points or 2.31%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 27, 2023 06:35 ET (10:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk